The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review
Abstract
Summary: Unfractionated heparin (UFH) remains the anticoagulant of choice during pregnancy. Low-molecular-weight heparins (LMWH) are an attractive alternative to UFH due to their logistic advantages and their association with a lower incidence of osteoporosis and HIT. We reviewed all published clinical reports concerning the use of LMWH during pregnancy. In addition, participants of an international interest group contributed a cohort of pregnant women treated with LMWH. Pregnancies were divided into two groups; those with and those without maternal comorbid conditions. The number of adverse fetal outcomes and the occurrence of maternal complications were evaluated in the two groups. In the group of women with comorbid conditions (n = 290), 13.4% of the pregnancies were associated with an adverse fetal outcome. In contrast, in the group of women without comorbid conditions (n = 196), 3.1% were associated with an adverse outcome, which is comparable to that seen in the normal population. We conclude that LMWH appear to be a safe alternative to unfractionated heparin as an anticoagulant during pregnancy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Warkentin, T. E., Levine, M. N., Hirsh, J., Horsewood, P., Roberts, R. S., Gent, M., & Kelton, J. G. (1995) · New England Journal of Medicine · doi:10.1056/nejm199505183322003 · Cited by 2,328
Weitz, J. I. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709043371007 · Cited by 1,533
Cohen, M., Demers, C., Gurfinkel, E. P., Turpie, A. G. G., Fromell, G. J., Goodman, S., Langer, A., Califf, R. M., Fox, K. A. A., Premmereur, J., et al. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708143370702 · Cited by 1,424
Collins, R., Scrimgeour, A., Yusuf, S., & Peto, R. (1988) · New England Journal of Medicine · doi:10.1056/nejm198805053181805 · Cited by 1,314
Rai, R., Cohen, H., Dave, M., & Regan, L. (1997) · BMJ · doi:10.1136/bmj.314.7076.253 · Cited by 1,113
Maternal and fetal sequelae of anticoagulation during pregnancy
Hall, J. G., Pauli, R. M., & Wilson, K. M. (1980) · The American Journal of Medicine · doi:10.1016/0002-9343(80)90181-3 · Cited by 997
Use of Antithrombotic Agents During Pregnancy
Ginsberg, J. S., & Hirsh, J. (1995) · Chest · doi:10.1378/chest.108.4_supplement.305s · Cited by 657
Self-citationDahlman, T. C. (1993) · American Journal of Obstetrics and Gynecology · doi:10.1016/0002-9378(93)90378-v · Cited by 379
Monréal, M., Lafoz, E., Olivé, A., et al. (1994) · PubMed · Cited by 352
Risks of Anticoagulant Therapy in Pregnant Women with Artificial Heart Valves
Iturbe-Alessio, I., Fonseca, M. D. C., Mutchinik, O., Santos, M. A., Zajarías, A., & Salazar, E. (1986) · New England Journal of Medicine · doi:10.1056/nejm198611273152205 · Cited by 307
Cited by
GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias)
Guyatt, G. H., Oxman, A. D., Vist, G., Kunz, R., Brozek, J., Alonso-Coello, P., Montori, V., Akl, E. A., Djulbegovic, B., & Falck-Ytter, Y. (2011) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2010.07.017 · Cited by 2,798
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy
Bates, S. M., Greer, I. A., Middeldorp, S., Veenstra, D. L., Prabulos, A.-M., & Vandvik, P. O. (2012) · Chest · doi:10.1378/chest.11-2300 · Cited by 1,525
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Linkins, L.-A., Dans, A. L., Moores, L. K., Bona, R., Davidson, B. L., Schulman, S., & Crowther, M. (2012) · Chest · doi:10.1378/chest.11-2303 · Cited by 1,018
Treatment and Prevention of Heparin-Induced Thrombocytopenia
Warkentin, T. E., Greinacher, A., Koster, A., & Lincoff, A. M. (2008) · Chest · doi:10.1378/chest.08-0677 · Cited by 816
Heparin-Induced Thrombocytopenia: Recognition, Treatment, and Prevention
Warkentin, T. E., & Greinacher, A. (2004) · Chest · doi:10.1378/chest.126.3_suppl.311s · Cited by 809
Metadata
- Authors
- Sanson, B.-J., Lensing, A., Prins, M., Ginsberg, J., Barkagan, Z., Lavenne-Pardonge, E., Brenner, B., Dulitzky, M., Nielsen, J., Boda, Z., Mac Gillavry, M., Hamulyák, K., Theunissen, I., Hunt, B., Büller, H., & Turi, S.
- Venue
- Thrombosis and Haemostasis
- Publisher
- Georg Thieme Verlag KG
- Published
- 1999
- Volume
- 81
- Issue
- 05
- Pages
- 668-672
- ISSN
- 0340-6245 (ISSN-L)
- 2567-689X
- OpenAlex
- W2145308085
- Cited by
- 539
- References
- 23
- FWCI
- 31.69
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review. https://app.cochat.ai/papers/10.1055/s-0037-1614550
- The paper
- Sanson, B.-J., Lensing, A., Prins, M., Ginsberg, J., Barkagan, Z., Lavenne-Pardonge, E., Brenner, B., Dulitzky, M., Nielsen, J., Boda, Z., Mac Gillavry, M., Hamulyák, K., Theunissen, I., Hunt, B., Büller, H., & Turi, S. (1999). Safety of Low-Molecular-Weight Heparin in Pregnancy: A Systematic Review. Thrombosis and Haemostasis. https://doi.org/10.1055/s-0037-1614550
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.